ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 685964 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 685964; 2) Community: the network communities that were significantly associated with the response to NSC 685964; 3) Molecule: the relationships between components within communities and NSC 685964; 4) MDR: the compounds that were significantly associated with the NSC 685964.

NSC Compound Enrichment Correlation
NSC 720250 Null 0.00349006332443474 -0.057580793
NSC 92423 Uridine, 2'-deoxy-5-(trifluoromethyl)-, 3',5'-bis(p-nitrobenzoate) 0.00349006332443474 0.20698028
NSC 745678 Null 0.00361053534040666 -0.1157094
NSC 105132 Deoxycamptothecin 0.00485717408280859 0.35592958
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.00485717408280859 0.36553792
NSC 357777 Null 0.00485717408280859 0.09482656
NSC 372939 Null 0.00485717408280859 0.11157769
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.00485717408280859 0.18513329
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.00485717408280859 0.44395622
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.00485717408280859 0.37517581
Total:139  Current:25    [First] [Prev] [Next] [Last]